1-3 of 3
Alfredo De La Torre
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Data on Outcomes of Anti-CD38 Antibody Refractory, Including Triple Class Refractory, Patients with Multiple Myeloma: A Multi-Institutional Report from the Canadian Myeloma Research Group (CMRG) Database

Alissa Visram, Alfredo De La Torre, Darrell White, Moustafa Kardjadj, Esther Masih-Khan, Michael P. Chu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Richard Leblanc, Kevin Song, Hira S Mian, Martha L Louzada, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Christopher P. Venner, Rayan Kaedbey, Engin Gul, Donna E. Reece
Journal: Blood
Blood (2022) 140 (Supplement 1): 4287–4289.
https://doi.org/10.1182/blood-2022-168843
Published: 2022
Journal Articles

Myeloma Patients with Deletion of 17p: Impact of Tandem Transplant and Clone Size

Alfredo De La Torre, Eshetu G Atenafu, Adam C. Smith, Vishal Kukreti, Anca Prica, Sita Bhella, Donna E. Reece, Rodger E Tiedemann, Suzanne Trudel, Christine I. Chen
Journal: Blood
Blood (2021) 138 (Supplement 1): 460.
https://doi.org/10.1182/blood-2021-153011
Published: 2021
Journal Articles

Progressive Multifocal Leukoencephalopathy in Multiple Myeloma: A Single Institution Case Series

Alfredo De La Torre, Andrew Gao, Timo Krings, Donna E. Reece
Journal: Blood
Blood (2021) 138 (Supplement 1): 4736.
https://doi.org/10.1182/blood-2021-152895
Published: 2021